Dalton WS - Search Results

1

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma.

Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL Jr. Modiano MR, et al. Among authors: dalton ws. Invest New Drugs. 1990 Aug;8(3):317-9. doi: 10.1007/BF00171846. Invest New Drugs. 1990. PMID: 2148744 Free article. Clinical Trial.

2

Ocular toxic effects of fenretinide.

Modiano MR, Dalton WS, Lippman SM, Joffe L, Booth AR, Meyskens FL Jr. Modiano MR, et al. Among authors: dalton ws. J Natl Cancer Inst. 1990 Jun 20;82(12):1063. doi: 10.1093/jnci/82.12.1063. J Natl Cancer Inst. 1990. PMID: 2140863 No abstract available.

3

Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients.

Peng YM, Dalton WS, Alberts DS, Xu MJ, Lim H, Meyskens FL Jr. Peng YM, et al. Among authors: dalton ws. Int J Cancer. 1989 Jan 15;43(1):22-6. doi: 10.1002/ijc.2910430106. Int J Cancer. 1989. PMID: 2521335

4

Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.

Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman SM. Sabichi AL, et al. Among authors: dalton ws. Clin Cancer Res. 2003 Jul;9(7):2400-5. Clin Cancer Res. 2003. PMID: 12855611

5

Mechanisms of drug resistance in breast cancer.

Dalton WS. Dalton WS. Semin Oncol. 1990 Aug;17(4 Suppl 7):37-9. Semin Oncol. 1990. PMID: 2200130 Review.

6

Expression of the MDR1 gene (P-glycoprotein) in breast cancer.

Weinstein RS, Hansen KK, McBeath RB, Dalton WS. Weinstein RS, et al. Among authors: dalton ws. Recent Results Cancer Res. 1993;127:49-54. doi: 10.1007/978-3-642-84745-5_7. Recent Results Cancer Res. 1993. PMID: 8099226 Review. No abstract available.

7

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease.

Miller TP, Chase EM, Dorr R, Dalton WS, Lam KS, Salmon SE. Miller TP, et al. Among authors: dalton ws. Anticancer Drugs. 1998 Feb;9(2):135-40. doi: 10.1097/00001813-199802000-00004. Anticancer Drugs. 1998. PMID: 9510499 Clinical Trial.

8

Cytogenetics and clinical correlations in breast cancer.

Emerson JC, Salmon SE, Dalton W, McGee DL, Yang JM, Thompson FH, Trent JM. Emerson JC, et al. Adv Exp Med Biol. 1993;330:107-18. doi: 10.1007/978-1-4615-2926-2_9. Adv Exp Med Biol. 1993. PMID: 8368128

9

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM. Taylor CW, et al. Among authors: dalton ws. Br J Cancer. 1991 Jun;63(6):923-9. doi: 10.1038/bjc.1991.202. Br J Cancer. 1991. PMID: 1676902 Free PMC article.

10

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

Pennock GD, Dalton WS, Roeske WR, Appleton CP, Mosley K, Plezia P, Miller TP, Salmon SE. Pennock GD, et al. Among authors: dalton ws. J Natl Cancer Inst. 1991 Jan 16;83(2):105-10. doi: 10.1093/jnci/83.2.105. J Natl Cancer Inst. 1991. PMID: 1988684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page